Evidence map›Paper›PMID 30116752›Full record

ArticleJournal of immunology research

Peptide-Based Immunotherapeutics and Vaccines 2017.

Pedro Reche, Darren R Flower, Masha Fridkis-Hareli, Yoshihiko Hoshino

Abstract readEditorial
In one paragraph

Article in Journal of immunology research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. mRNA-based therapeutic strategies for cancer treatment.Molecular therapy : the journal of the American Society of Gene Therapy · 2024
    Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. The Delivery of mRNA Vaccines for Therapeutics.Life (Basel, Switzerland) · 2022
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Peptide-Based Vaccination Therapy for Rheumatic Diseases.Journal of immunology research · 2020
    Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Pedro RecheDepartment of Immunology & O2, Facultad de Medicina, Universidad Complutense, 28040 Madrid, Spain.ORCID 0000-0003-3966-5838
Darren R FlowerSchool of Life and Health Sciences, Aston University, Birmingham B4 7ET, UK.ORCID 0000-0002-8542-7067
Masha Fridkis-HareliATR, LLC, Worcester, MA 01606, USA.ORCID 0000-0002-8534-8182
Yoshihiko HoshinoDepartment of Mycobacteriology, National Institute of Infectious Diseases, Higashi-Murayama, Tokyo 189-0002, Japan.ORCID 0000-0002-3132-0715

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsB-LymphocytesHumansImmunityImmunizationImmunodominant EpitopesImmunotherapyInfectionsT-LymphocytesVaccines, SubunitImmunodominant EpitopesVaccines, Subunit

Identifiers

PMID30116752
PMCPMC6079504

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.